November 2017

How to Apply the Golden Rule of Research to Your Trial Master File

Good Documentation PracticeWhite (GDP) is the cornerstone to ensuring a quality, inspection ready Trial Master File (TMF). TMF experts, LMK Clinical Research strongly believe that GDP is the responsibility of everyone that contributes (i.e. via submission or creation) clinical trial documentation to the TMF. 

In this white paper, LMK evaluates the following:

  • Regulations that support GDP
  • Best practices on how document contributors can apply the golden rule of research to their TMF
  • How to avoid writing too many and unnecessary Note-to-Files (NTFs)
  • Tips on becoming inspection ready and staying that way

Request the
White paper



ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.